Ian is the editor and a director of Proactive Investors. He oversees all editorial output and is also heavily involved with business development. He moved to Proactive from the Daily Mail, where he was City News Editor and Investment Editor and brings with him a wealth of experience in business and finance. At the Mail he directed the coverage of some of the biggest stories ever to emerge from the City as the credit crunch and banking crisis felled some of the nation's best known financial institutions. In his 20 years as a business reporter and editor Ian has worked for Dow Jones, writing stories for the international news wire and the Wall Street Journal. He also led the London company coverage for AFX News, now part of Reuters.
The first three patients in a group taking part in the Phase II portion of the study were able on average able to read an additional three lines of on the standard ETDRS eye chart after receiving treatment
"This highly earnings enhancing acquisition of US rights to Proleukin is significant to the whole group, not just the commercial medicines division,” said chief executive Shaun Chilton
“With this funding and growing revenues, the cash position remains strong and sufficient to cover the delivery of existing commercial plans,” investors were told
First-in-man studies of the ROCK2 technology will take place next year
OptiBiotix chief executive Stephen O’Hara said: “This is a significant achievement and a major commercial milestone as it expands the potential applications of LPLDL from use as a supplement to use as a functional ingredient"
Executive chairman Jonathan Peacock will stay in role, but in a non-executive capacity
Seneca Partners’ holding in the company increases to 20.9% from 14.6% after it bought stock at 16 pence
Dr Cath O'Neill told investors: "I am determined to find a suitable individual for the CEO role with the same passion for the science, as well as commercial acumen"
Two companies, three wells
Drilling down into the world of E&P as we keep tabs of on the gushers and dusters
A look at some early analyst views in the City
The bookmakers have been put under the microscope, while Shell has been downgraded.